Stock Taper
SCREENER COMPARE ANY 2 STOCKS
OABI
OMNIAB, INC.
NASDAQ
$4.33
▼ DOWN 8.84% (-0.42)

KEY STATISTICS

Market Cap$624.83 M
52w High$5.43
52w Low$1.30
Dividend Yield—
Frequency—
P/E-12.03
Volume1.70M
Shares Out.144.97M

COMPANY

LEADERSHIP

Matthew W. Foehr
CHIEF EXECUTIVE
Matthew W. Foehr

COMPENSATION 2026

Salary$541,658
Stock Awards$2,019,986
Incentive Plan Pay$311,454
All Other Comp.$114,604
Total$6,656,243

ABOUT

SECTOR
Healthcare
WENT PUBLIC
September 30, 2021
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
89

PRICE TARGET

Target High$4.00
Target Low$4.00
Target Median$4.00
Target Consensus$4.00

UPCOMING EARNINGS

DateNov 3, 2026
DayTuesday
Rev. Est.$3.43M
NOV
3
TUE

PRICE

$4.33 ▼ DOWN 8.84% (−$0.42)
$4.35$4.50$4.65$4.809:30 AM10:35 AM11:40 AM12:44 PM1:49 PM2:54 PM3:59 PM4.33

About OmniAb, Inc.

https://www.omniab.com ↗

OmniAb, Inc. provides innovative antibody discovery platforms using genetically engineered transgenic animals to enable development of next-generation therapeutics and bispecific antibodies.

INDUSTRY

Biotechnology

A SERVICE OMNIAB, INC. IS KNOWN FOR

OmniUltra Platform

OmniUltra is a pioneering in vivo platform launched in December 2025, utilizing transgenic chickens to discover novel therapeutic antibodies and peptides with ultralong CDRH3 domains for challenging targets.

COMPETITORS

COMPETITOR
ABCL COMPARE
REGN COMPARE
SDGR COMPARE
TWST COMPARE
XNCR COMPARE

Revenue by Products

IconPRODUCTQ1-2025Q2-2025Q3-2025Q4-2025
Service$1.95M $1.94M ▼$1.19M ▼$2.19M ▲
Royalty$188K $111K ▼$361K ▲$218K ▼

ETFS HOLDING THIS STOCK

ETFS HOLDING
87
LISTED HERE
12
RANKED BY POSITION SIZE
VTS.AX
0.00% · 2.8M
IWM
0.02% · 2.8M
SCHA
0.01% · 555.1K
FESM
0.02% · 215.4K
R2SC.L
0.02% · 196.2K
GSSC
0.08% · 164.4K
AVSC
0.02% · 105.3K
PRFZ
0.02% · 89.8K
XRSU.L
0.02% · 89.2K
DFMC
0.01% · 82.6K
RSSL
0.02% · 52.7K
BIB
0.02% · 5.2K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
48.83%
HOLDERS
183
TOP 12 OF 183 · RANKED BY POSITION SIZE
Avista Capital Holdings, L.P.
15.8M sh · $64.32B
Whitefort Capital Management, LP
14.2M sh · $26.31M
Blackrock, Inc.
8.1M sh · $12.73M
Blackrock Inc.
7.0M sh · $26.39M
Vanguard Group Inc
5.6M sh · $10.41M
Cadian Capital Management, LP
4.4M sh · $8.2M
Geode Capital Management, LLC
2.9M sh · $4.59M
Woodline Partners LP
2.9M sh · $4.57M
Dimensional Fund Advisors LP
2.5M sh · $4.08M
Rice Hall James & Associates, LLC
2.5M sh · $4M
Private Management Group Inc
2.5M sh · $4.03M
Stonepine Capital Management, LLC
2.1M sh · $3.43M

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity3
Price To Earnings1
Price To Book4
Overall Score2

INSIDER TRADES

★
OFFICER: CHIEF OPERATING OFFICER
Nwachuku Amechi Ekeke
Purchase · 800.0K shares
2026-08-01
★
OFFICER
Nwachuku Amechi Ekeke
— · —
2026-07-13
★
DIRECTOR
HIGGINS JOHN L
Purchase · 40.0K shares
2026-06-17
★
DIRECTOR
HIGGINS JOHN L
Purchase · 20.0K shares
2026-06-17

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 1
1 GRADES IN THE LAST 12 MONTHS
HC Wainwright & Co. BUY

SECTORS PEERS

PEERPRICE
CCCC$3.81COMPARE
IVVD$0.81COMPARE
TARA$3.94COMPARE
IPHA$2.05COMPARE
CDXS$1.45COMPARE
MIST$1.21COMPARE
IMDX$4.10COMPARE
RANI$0.88COMPARE